And it starts with study design.
We know clinical trial complexity is increasing, so let’s investigate how it's happening across most dimensions of trial planning and management.
Ingesting, integrating, standardizing, cleaning, coding, and analyzing disparate data sources creates complexity.
Discoveries driven by genomic data could dramatically increase the number of biomarkers available for use in clinical trials.
The world's oncology pipeline is rapidly growing, with nearly 40% of the global clinical pipeline focused on immuno-oncology.